ACM
CGON icon

Aquatic Capital Management’s CG Oncology CGON Stock Holding History

Aquatic Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$822K Sell
11,568
-38,060
-77% -$2.49M 0.03% 619
2026
Q1 		$3.36M Buy
+49,628
New +$2.81M 0.1% 266

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Aquatic Capital Management's CGON Position: Q2 2026 in Review

Aquatic Capital Management reduced its CG Oncology (CGON) stake by 77% in Q2 2026, selling an estimated $2.49M and leaving 11,568 shares worth $822K. The position accounts for 0.03% of the portfolio, ranked #619.

Aquatic Capital Management first reported a position in CGON in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.36M in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Aquatic Capital Management held 11,568 shares of CG Oncology worth $822K as of Q2 2026.
  • Aquatic Capital Management sold 38,060 CG Oncology shares in Q2 2026, an estimated $2.49M.
  • CG Oncology made up 0.03% of Aquatic Capital Management's portfolio in Q2 2026, its #619 holding.
  • Aquatic Capital Management first reported a position in CG Oncology in Q1 2026 and has held it in 2 quarters since.
  • Aquatic Capital Management's CG Oncology position peaked at $3.36M in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.